OneMedNet Announces iRWD Customer Data License Agreement With Leading U.S.-Based Global Clinical Trial Design And Software Company; Provides Regulatory-Grade Real World Data Including EHRs, Lab Results, And Medical Imaging
Portfolio Pulse from Benzinga Newsdesk
OneMedNet has announced a customer data license agreement with a leading U.S.-based global clinical trial design and software company. The agreement will provide regulatory-grade real-world data, including EHRs, lab results, and medical imaging.
June 14, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OneMedNet has entered into a significant data license agreement with a leading clinical trial design and software company, enhancing its offerings with regulatory-grade real-world data.
The agreement is likely to enhance OneMedNet's product offerings and market position by providing high-quality, regulatory-grade data. This could attract more clients and partnerships, positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100